Form 4: CEL-SCI Corp Executive Eyal Talor Acquires Additional Shares
SEC Form 4 Filing
Chief Scientific Officer Eyal Talor reports the acquisition of 2,068 shares of CEL-SCI Corp common stock at $1.16 per share.
Summary
- On June 28, 2024, Eyal Talor, Chief Scientific Officer of CEL-SCI Corp, acquired 2,068 shares of common stock.
- The acquisition price was $1.16 per share.
- Following the transaction, Talor directly owns 116,332 shares of CEL-SCI Corp.
Sentiment
Score: 6
Explanation: Neutral sentiment. The document simply reports a transaction. The purchase of shares by an officer is mildly positive, suggesting confidence, but it's a small transaction.
Positives
- The acquisition of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, which is required when a company insider buys or sells shares of their company's stock. It provides transparency into the transactions of company executives and directors.
Stakeholder Impact
- The acquisition of shares by a company officer may have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of transaction: Eyal Talor acquired 2,068 shares of CEL-SCI Corp common stock. |
| 07/01/2024 | Signature date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.